<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37295581</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Travel medicine and infectious disease</Title><ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The global challenges of the long COVID-19 in adults and children.</ArticleTitle><Pagination><StartPage>102606</StartPage><MedlinePgn>102606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2023.102606</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1477-8939(23)00066-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodriguez-Morales</LastName><ForeName>Alfonso J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas-Instituci&#xf3;n Universitaria Visi&#xf3;n de las Am&#xe9;ricas, Pereira, 660003, Risaralda, Colombia; Faculty of Health Sciences, Universidad Cient&#xed;fica del Sur, Lima, 15067, Peru; Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon. Electronic address: alfonso.rodriguez@uam.edu.co.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Echeverri</LastName><ForeName>Mar&#xed;a Camila</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Raga</LastName><ForeName>Maria Fernanda</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintero-Romero</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia-Gallego</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galindo-Herrera</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Alzate</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Vinasco</LastName><ForeName>Juan Diego</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Vargas</LastName><ForeName>Juan Jos&#xe9;</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayta-Tristan</LastName><ForeName>Percy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Universidad Cient&#xed;fica del Sur, Lima, 15067, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husni</LastName><ForeName>Rola</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghnieh</LastName><ForeName>Rima</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephan</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faour</LastName><ForeName>Wissam</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tawil</LastName><ForeName>Samah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barakat</LastName><ForeName>Hanane</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaaban</LastName><ForeName>Toufic</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Megarbane</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizk</LastName><ForeName>Youssef</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakr</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, 1102, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escalera-Antezana</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Direction of First Level, Municipal Secretary of Health, Municipal Autonomous Government of Cochabamba, Cochabamba, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarado-Arnez</LastName><ForeName>Lucia E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>National Research Coordination, Franz Tamayo University (UNIFRANZ), La Paz, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla-Aldana</LastName><ForeName>D Katterine</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Research Unit, Universidad Continental, Huancayo, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho-Moreno</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Universidad Nacional de Colombia, Bogot&#xe1;, DC, Colombia; Division of Infectious Diseases, HOMI, Hospital Pedi&#xe1;trico La Misericordia, Bogot&#xe1;, DC, Colombia; Fundaci&#xf3;n Hospital Infantil Universitario de San Jos&#xe9;, Bogot&#xe1;, DC, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hemera Unidad de Infectolog&#xed;a IPS SAS, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Sabogal</LastName><ForeName>Ivan Arturo</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Hospital San Vicente Fundaci&#xf3;n, Rionegro, Antioquia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mill&#xe1;n-O&#xf1;ate</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinica Imbanaco Grupo Quironsalud, Cali, Colombia; Universidad Santiago de Cali, Cali, Colombia; Clinica de Occidente, Cali, Colombia; Clinica Sebasti&#xe1;n de Belalcazar, Valle del Cauca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopardo</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>C&#xe1;tedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Alexandre Naime</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Botucatu Medical School, UNESP, Brazilian Society for Infectious Diseases, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimerman</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases Emilio Ribas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaves</LastName><ForeName>T&#xe2;nia do Socorro Souza</ForeName><Initials>TDSS</Initials><AffiliationInfo><Affiliation>Evandro Chagas Institute, Health of Ministry of Brazil, Bel&#xe9;m, Par&#xe1;, Brazil; Faculdade de Medicina da Universidade Federal do Par&#xe1;, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orduna</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>C&#xe1;tedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires, Argentina; Hospital de Enfermedades Infecciosas F. J. Mu&#xf1;iz, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lloveras</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>C&#xe1;tedra de Enfermedades Infecciosas, University of Buenos Aires, Buenos Aires, Argentina; Hospital de Enfermedades Infecciosas F. J. Mu&#xf1;iz, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Morales</LastName><ForeName>Andrea G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Unidad Procedimientos, Policl&#xed;nico Neurolog&#xed;a, Centro de Referencia de Salud Dr. Salvador Allende Gossens, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thormann</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Salvador Bienvenido Gautier, Santo Domingo, Dominican Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambrano</LastName><ForeName>Patricia Gabriela</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Jefatura de C&#xe1;tedra de Enfermedades Infecciosas, Universidad Central del Ecuador, Quito, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Clevy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universidad Aut&#xf3;noma de Santo Domingo, Santo Domingo, Dominican Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital Roosevelt, Guatemala City, Guatemala.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zambrano</LastName><ForeName>Lysien</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Research in Medical Sciences and Right to Health (ICIMEDES), National Autonomous University of Honduras (UNAH), Tegucigalpa, Honduras.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Moreno</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>National Clinical Coordinator COVID-19-WHO Studies, Colombia; Clinica Universitaria Colombia, Clinica Colsanitas and Facultad de Medicina, Universidad Nacional de Colombia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chacon-Cruz</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Think Vaccines LLC, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villamil-Gomez</LastName><ForeName>Wilmer E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Ciencias de la Vida, Universidad Sim&#xf3;n Bol&#xed;var, Barranquilla, Colombia; Grupo de Expertos Cl&#xed;nicos Secretaria de Salud de Barranquilla, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benites-Zapata</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n para la Generaci&#xf3;n y S&#xed;ntesis de Evidencias en Salud, Vicerrectorado de Investigaci&#xf3;n, Universidad San Ignacio de Loyola, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savio-Larriera</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Evang&#xe9;lico de Montevideo, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardona-Ospina</LastName><ForeName>Jaime A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n Biomedicina, Faculty of Medicine, Fundaci&#xf3;n Universitaria Aut&#xf3;noma de las Am&#xe9;ricas, Pereira, 660003, Colombia; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, 94704, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risquez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forero-Pe&#xf1;a</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela; Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henao-Mart&#xed;nez</LastName><ForeName>Andr&#xe9;s F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, School of Medicine, University of Colorado Anschutz Medical Campus, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sah</LastName><ForeName>Ranjit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal; Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune, 411018, Maharashtra, India; Department of Public Health Dentistry, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barboza</LastName><ForeName>Joshuan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Escuela de Medicina, Universidad Cesar Vallejo, Trujillo, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Figueroa</LastName><ForeName>Darwin A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Facultad de Medicina Humana, Universidad de San Mart&#xed;n de Porres, Chiclayo, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta-Espa&#xf1;a</LastName><ForeName>Jaime David</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, Friedrich Schiller University Jena, Beutenbergstra&#xdf;e 13, 07745, Jena, Germany; Postgraduate Program in Infectious Diseases, School of Medicine, Pontificia Universidad Cat&#xf3;lica del Ecuador, Quito, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrero-Gonzalez</LastName><ForeName>Carmen Mar&#xed;a</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Universidad Sim&#xf3;n Bolivar, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Tawfiq</LastName><ForeName>Jaffar A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, 34465, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, 47405, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabaan</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, 11533, Saudi Arabia; Department of Public Health and Nutrition, The University of Haripur, Haripur, 22610, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leblebicioglu</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, VM Medicalpark Samsun Hospital, Samsun, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales-Zamora</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulloa-Guti&#xe9;rrez</LastName><ForeName>Rolando</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Infectolog&#xed;a Pedi&#xe1;trica, Hospital Nacional de Ni&#xf1;os "Dr. Carlos S&#xe1;enz Herrera", Centro de Ciencias M&#xe9;dicas, Caja Costarricense de Seguro Social (CCSS), San Jos&#xe9;, Costa Rica; Instituto de Investigaci&#xf3;n en Ciencias M&#xe9;dicas UCIMED (IICIMED), San Jos&#xe9;, Costa Rica; C&#xe1;tedra de Pediatr&#xed;a, Facultad de Medicina, Universidad de Ciencias M&#xe9;dicas (UCIMED), San Jos&#xe9;, Costa Rica.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Travel Med Infect Dis</MedlineTA><NlmUniqueID>101230758</NlmUniqueID><ISSNLinking>1477-8939</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37295581</ArticleId><ArticleId IdType="pmc">PMC10247301</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2023.102606</ArticleId><ArticleId IdType="pii">S1477-8939(23)00066-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhama K., Khan S., Tiwari R., Sircar S., Bhat S., Malik Y.S., et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405836</ArticleId><ArticleId IdType="pubmed">32580969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Cardona-Ospina J.A., Guti&#xe9;rrez-Ocampo E., Villamizar-Pe&#xf1;a R., Holguin-Rivera Y., Escalera-Antezana J.P., et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Trav Med Infect Dis. 2020;34</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahat R.A., Abdelaal A., Umar T.P., El-Sakka A.A., Benmelouka A.Y., Albakri K., et al. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends. Inf Med. 2022;30:480&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714996</ArticleId><ArticleId IdType="pubmed">36482957</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcolino M.S., Ziegelmann P.K., Souza-Silva M.V.R., Nascimento I.J.B., Oliveira L.M., Monteiro L.S., et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021;107:300&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801187</ArticleId><ArticleId IdType="pubmed">33444752</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ara&#xfa;jo G.R., de Castro P., &#xc1;vila I.R., Bezerra J.M.T., Barbosa D.S. Effects of public health emergencies of international concern on disease control: a systematic review. Rev Panam Salud P&#xfa;blic. 2023;47:e74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10120386</ArticleId><ArticleId IdType="pubmed">37089787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Gallego V., Escalera-Antezana J.P., M&#xe9;ndez C.A., Zambrano L.I., Franco-Paredes C., et al. COVID-19 in Latin America: the implications of the first confirmed case in Brazil. Trav Med Infect Dis. 2020;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129040</ArticleId><ArticleId IdType="pubmed">32126292</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimerman S., Chebabo A., Cunha C.A.D., Rodr&#xed;guez-Morales A.J. Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil. Braz J Infect Dis. 2020;24:93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177128</ArticleId><ArticleId IdType="pubmed">32335078</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimerman S., Chebabo A., Cunha C.A.D., Rodr&#xed;guez-Morales A.J. One year after the arrival of COVID-19 in Latin America: what have we learned in Brazil and other countries? Braz J Infect Dis. 2021;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392129</ArticleId><ArticleId IdType="pubmed">33741322</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazerji S.S., Shahabinejad F., Tokasi M., Rad M.A., Khan M.S., Safdar M., et al. Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene reports. 2022;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8761036</ArticleId><ArticleId IdType="pubmed">35071820</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet (London, England) 2022;399:1513&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies R.M., O'Sullivan O., Senaratne K.P.P., Baker P., Cranley M., Dharm-Datta S., et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54:949&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Karzai F., Madan R.A., Dahut W.L. The world of clinical trial development post COVID-19: lessons learned from a global pandemic. Clin Cancer Res. 2020;26:4198&#x2013;4200.</Citation><ArticleIdList><ArticleId IdType="pubmed">32503806</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B., Seang S., Tubiana R., de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26:1448&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G., Barco S., Endres M., Geelhoed J.J.M., Knauss S., et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O., Lui L.M.W., Eskander S., Ceban F., Ho R., Di Vincenzo J.D., et al. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Morales A.J., Simon F. Chronic chikungunya, still to be fully understood. Int J Infect Dis. 2019;86:133&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">31369822</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral J.K., Bingham C.O., 3rd, Taylor P.C., Vil&#xe1; L.M., Weinblatt M.E., Schoen R.T. Pathogenesis of chronic chikungunya arthritis: resemblances and links with rheumatoid arthritis. Trav Med Infect Dis. 2023;52</Citation><ArticleIdList><ArticleId IdType="pubmed">36549417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-Ospina J.A., Rodr&#xed;guez-Morales A.J., Teixeira M.G., G&#xe9;rardin P. vol. 70. Arthritis &amp; rheumatology; Hoboken, NJ): 2018. p. 1891. (Need for Accurate and Consistent Definition of Chronic Chikungunya Arthritis: comment on the Article by Chang et al).</Citation><ArticleIdList><ArticleId IdType="pubmed">30003715</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A.E., Rodriguez-Morales A.J., Blohm G., Marquez M., Villamil-Gomez W.E. ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics. Ann Clin Microbiol Antimicrob. 2016;15:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4957883</ArticleId><ArticleId IdType="pubmed">27449770</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Gil-Restrepo A.F., Ramirez-Jaramillo V., Montoya-Arias C.P., Acevedo-Mendoza W.F., Bedoya-Arias J.E., et al. vol. 5. 2016. p. 360. (Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia). F1000Res.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4813633</ArticleId><ArticleId IdType="pubmed">27081477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Restrepo-Posada V.M., Acevedo-Escalante N., Rodriguez-Munoz E.D., Valencia-Marin M., Castrillon-Spitia J.D., et al. Impaired quality of life after chikungunya virus infection: a 12-month follow-up study of its chronic inflammatory rheumatism in La Virginia, Risaralda, Colombia. Rheumatol Int. 2017;37:1757&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pubmed">28828632</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-Ospina J.A., Zapata M.F., Grajales M., Arias M.A., Grajales J., Bedoya-Rend&#xf3;n H.D., et al. Physical growth and neurodevelopment of a cohort of children after 3.5 Years of follow-up from mothers with Zika infection during pregnancy-third report of the ZIKERNCOL study. J Trop Pediatr. 2021;67</Citation><ArticleIdList><ArticleId IdType="pubmed">34037794</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Morales A.J., Bonilla-Aldana D.K., Bonilla-Aldana J.L., Arteaga-Livias K., Pecho-Silva S., Escalera-Antezana J.P. Role of Zika virus infection in cases and outbreaks of Guillain-Barr&#xe9; syndrome in Latin America: pooling the prevalence of studies. Trav Med Infect Dis. 2021;39</Citation><ArticleIdList><ArticleId IdType="pubmed">33137492</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester J.V. Ebola virus and persistent chronic infection: when does replication cease? Ann Transl Med. 2018;6:S39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291550</ArticleId><ArticleId IdType="pubmed">30613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita M., Diallo B., Mesfin S., Marega A., Nebie K.Y., Magassouba N., et al. Subsequent mortality in survivors of Ebola virus disease in Guinea: a nationwide retrospective cohort study. Lancet Infect Dis. 2019;19:1202&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">31494017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano L.I., Fuentes-Barahona I.C., Portillo-Pineda R., Aguilar-Ponce M., Murillo-Padilla J.C., Suazo-Menocal M., et al. Assessment of post-dengue rheumatic symptoms using the WOMAC and DAS-28 questionnaires in a Honduran population after a four-month follow-up. Trop. Med. Infect. Dis. 2022;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9784921</ArticleId><ArticleId IdType="pubmed">36548649</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.K., Malone L.A., Kokorelis C., Petracek L.S., Eastin E.F., Lobner K.L., et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr. Pediatr. Rep. 2022;10:31&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906524</ArticleId><ArticleId IdType="pubmed">35287333</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re'em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMed. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Islam M., Conroy K., Cotler J., Torres C., Johnson M., et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue : Biomed. Health. Behav. 2021;9:59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O'Brien C., Savinelli S., Tinago W., Yousif O., et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tami A., van der Gun B.T.F., Wold K.I., Vincenti-Gonz&#xe1;lez M.F., Veloo A.C.M., Knoester M., et al. The COVID HOME study research protocol: prospective cohort study of non-hospitalised COVID-19 patients. PLoS One. 2022;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9632784</ArticleId><ArticleId IdType="pubmed">36327223</ArticleId></ArticleIdList></Reference><Reference><Citation>Barboza A.P., Luna-Muschi A., Leal F., Mendes E., Manuli E., Ghilardi F., et al. 2023. Long COVID in Brazil: a multicentre study 12. COVID-19 epidemiology - local, regional, national, global. Abstract. 33rd European congress of clinical Microbiology and infectious diseases (ECCMID 2023) Copenhaguen, Denmark, April 15-18, 2023.</Citation></Reference><Reference><Citation>WHO . 2023. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus.https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1. 2023</Citation></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini A.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Shetty A., Delanerolle G., Zeng Y., Zhang Y., Raymont V., et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12:88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampl B.M.J., Leitzmann M.F., Salzberger B. Prevalence of post-COVID-19 conditions depends on the method of assessment. J Infect Dis. 2023;227:306.</Citation><ArticleIdList><ArticleId IdType="pubmed">36546758</ArticleId></ArticleIdList></Reference><Reference><Citation>Servier C., Porcher R., Pane I., Ravaud P., Tran V.-T. Trajectories of the evolution of post COVID-19 condition, up to two years after symptoms onset. Int J Infect Dis. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10176960</ArticleId><ArticleId IdType="pubmed">37182548</ArticleId></ArticleIdList></Reference><Reference><Citation>Aby E.S., Moafa G., Latt N., Sultan M.T., Cacioppo P.A., Kumar S., et al. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol. Commun. 2023;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9827967</ArticleId><ArticleId IdType="pubmed">36633476</ArticleId></ArticleIdList></Reference><Reference><Citation>Granholm A.C. Long-term effects of SARS-CoV-2 in the brain: clinical consequences and molecular mechanisms. J Clin Med. 2023:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10179128</ArticleId><ArticleId IdType="pubmed">37176630</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., TKP Naing, Garg P., et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Garout M.A., Saleh S.A.K., Adly H.M., Abdulkhaliq A.A., Khafagy A.A., Abdeltawab M.R., et al. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection. 2022;50:1431&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924350</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId></ArticleIdList></Reference><Reference><Citation>Saaavedra-Trujillo C.H., et al. Consenso colombiano de atenci&#xf3;n, diagn&#xf3;stico y manejo de la infecci&#xf3;n por SARS-COV-2/COVID-19 en establecimientos de atenci&#xf3;n de la salud - recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24:1&#x2013;102.</Citation></Reference><Reference><Citation>Franke C., Berlit P., Pr&#xfc;ss H. Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology. Neurol. Res. Pract. 2022;4:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9288923</ArticleId><ArticleId IdType="pubmed">35843984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngeow W.C., Tang L., Ho J.Y., Tay H.W., Wong R.C.W., Ahmad M.S., et al. The provision of dental care to COVID-19 survivors: a concise review. Int Dent J. 2022;72:421&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156960</ArticleId><ArticleId IdType="pubmed">35752482</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath L.J., Scott A.M., Surinach A., Chambers R., Benigno M., Malhotra D. Use of the postacute sequelae of COVID-19 diagnosis code in routine clinical practice in the US. JAMA Netw Open. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539719</ArticleId><ArticleId IdType="pubmed">36201207</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Hare A.M., Vig E.K., Iwashyna T.J., Fox A., Taylor J.S., Viglianti E.M., et al. Complexity and challenges of the clinical diagnosis and management of long COVID. JAMA Netw Open. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9634500</ArticleId><ArticleId IdType="pubmed">36326761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorfman D., Berger Z. Approving workplace accommodations for patients with long covid - advice for clinicians. N Engl J Med. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">37272533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallegos M., Morgan M.L., Burgos-Videla C., Caycho-Rodr&#xed;guez T., Martino P., Cervigni M. The impact of long Covid on people&#x2019;s capacity to work. Ann. Work Expos. Health. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">37253159</ArticleId></ArticleIdList></Reference><Reference><Citation>Update to living WHO guideline on drugs to prevent covid-19. BMJ. 2023;380:692.</Citation><ArticleIdList><ArticleId IdType="pubmed">36958748</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudofker E.W., Parker H., Cornwell W.K., 3rd An exercise prescription as a novel management strategy for treatment of long COVID. JACC Case Rep. 2022;4:1344&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9580598</ArticleId><ArticleId IdType="pubmed">36278147</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich J., Rosen C.J. Toward comprehensive care for long covid. N Engl J Med 2023. in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">37158440</ArticleId></ArticleIdList></Reference><Reference><Citation>Manu P. Therapeutic vaccination is the most promising intervention for long COVID. Am J Therapeut. 2023 in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">37235337</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Perrodeau E., Saldanha J., Pane I., Ravaud P. Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort. BMJ Med. 2023;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla-Aldana D.K., Quintero-Rada K., Montoya-Posada J.P., Ramirez-Ocampo S., Paniz-Mondolfi A., Rabaan A.A., et al. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronaviruses? - a bibliometric analysis. Trav Med Infect Dis. 2020;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129460</ArticleId><ArticleId IdType="pubmed">32007621</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell J.S., Chappell K.J. Chronic SARS-CoV-2, a cause of post-acute COVID-19 sequelae (Long-COVID)? Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term gastrointestinal outcomes of COVID-19. Nat Commun. 2023;14:983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokel-Walker C. How long does SARS-CoV-2 stay in the body? BMJ. 2022;377:o1555.</Citation><ArticleIdList><ArticleId IdType="pubmed">35764342</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussenblatt V., Roder A.E., Das S., de Wit E., Youn J.H., Banakis S., et al. Yearlong COVID-19 infection reveals within-host evolution of SARS-CoV-2 in a patient with B-cell depletion. J Infect Dis. 2022;225:1118&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755281</ArticleId><ArticleId IdType="pubmed">34940844</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Li S., Pan Y., Qin L., Yang S., Tan D., et al. An immunocompetent patient with high neutralizing antibody titers who shed COVID-19 virus for 169 days - China, 2020. China CDC weekly. 2021;3:688&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8393007</ArticleId><ArticleId IdType="pubmed">34594968</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Lago L., Ald&#xe1;miz-Echevarr&#xed;a T., Garc&#xed;a-Mart&#xed;nez R., P&#xe9;rez-Latorre L., Herranz M., Sola-Campoy P.J., et al. Different within-host viral evolution dynamics in severely immunosuppressed cases with persistent SARS-CoV-2. Biomedicines. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8301427</ArticleId><ArticleId IdType="pubmed">34356872</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf R.E., Anaya J.M. Post-COVID syndrome in adults-an overview. Viruses. 2023;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10056158</ArticleId><ArticleId IdType="pubmed">36992384</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodriguez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.Z., et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med. 2022;20:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Herran M., Beltran S., Rojas M. Is post-COVID syndrome an autoimmune disease? Expet Rev Clin Immunol. 2022;18:653&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">35658801</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodriguez Y., Roa G., Lozano M., et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Saito M., Tamura A., Prawisuda D., Mizutani T., Yotsuyanagi H. The human microbiome and COVID-19: a systematic review. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221462</ArticleId><ArticleId IdType="pubmed">34161373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei N., Zhu G., Zhao T., Wang Y., Lou H., Li H., et al. Characterization of oral bacterial and fungal microbiome in recovered COVID-19 patients. BMC Microbiol. 2023;23:123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166687</ArticleId><ArticleId IdType="pubmed">37158877</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70:61&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Peyser N.D., Lin F., Knight S.J., Djibo A., et al. Factors associated with long covid symptoms in an online cohort study. medRxiv. 2022 preprint.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022;42:1523&#x2013;1530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., Furst J., Schulze-Rothe S., Wallukat A., et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Guio D.A., Villamil-G&#xf3;mez W.E., Dajud L., P&#xe9;rez-D&#xed;az C.E., Bonilla-Aldana D.K., Mondragon-Cardona A., et al. Will the Colombian intensive care units collapse due to the COVID-19 pandemic? Trav Med Infect Dis. 2020;38</Citation><ArticleIdList><ArticleId IdType="pubmed">33353596</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar M., Selvaraj S.A., Lee K.E., Caraballo-Arias Y., Harrell M., Rodriguez-Morales A.J. Healthcare workers, epidemic biological risks - recommendations based on the experience with COVID-19 and Ebolavirus. Inf Med. 2022;30:168&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177174</ArticleId><ArticleId IdType="pubmed">35693057</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Duque J.A., Arce-Villalobos L.R., Rodr&#xed;guez-Morales A.J. [Coronavirus disease 2019 (COVID-19) in Latin America: role of primary care in preparedness and response] Atenci&#xf3;n Primaria. 2020;52:369&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164864</ArticleId><ArticleId IdType="pubmed">32386927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Mart&#xed;nez Y., Garcia-Robledo J.E., V&#xe1;squez-Casta&#xf1;eda D.L., Bonilla-Aldana D.K., Rodriguez-Morales A.J. Can Google&#xae; trends predict COVID-19 incidence and help preparedness? The situation in Colombia. Trav Med Infect Dis. 2020;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187809</ArticleId><ArticleId IdType="pubmed">32360323</ArticleId></ArticleIdList></Reference><Reference><Citation>Escalera-Antezana J.P., Lizon-Ferrufino N.F., Maldonado-Alanoca A., Alarc&#xf3;n-De-la-Vega G., Alvarado-Arnez L.E., Balderrama-Saavedra M.A., et al. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Trav Med Infect Dis. 2020;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129170</ArticleId><ArticleId IdType="pubmed">32247926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Paniz-Mondolfi A.E., Faccini-Mart&#xed;nez &#xc1; A., Henao-Mart&#xed;nez A.F., Ruiz-Saenz J., Martinez-Gutierrez M., et al. The constant threat of zoonotic and vector-borne emerging tropical diseases: living on the edge. Front Trop Dis. 2021;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132189</ArticleId><ArticleId IdType="pubmed">34010366</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L.S., Reiners S., Becker J., Hertel G. Long-term effects of COVID-19 on work routines and organizational culture - a case study within higher education's administration. J Bus Res. 2023;163</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10073594</ArticleId><ArticleId IdType="pubmed">37056239</ArticleId></ArticleIdList></Reference><Reference><Citation>Landhuis E.W. How primary care physicians can recognize and treat long COVID. JAMA. 2023;329:1727&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pubmed">37133827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Le&#xf3;n-Figueroa D.A., Roman&#xed; L., McHugh T.D., Leblebicioglu H. Vaccination of children against COVID-19: the experience in Latin America. Ann Clin Microbiol Antimicrob. 2022;21:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949833</ArticleId><ArticleId IdType="pubmed">35337354</ArticleId></ArticleIdList></Reference><Reference><Citation>Solante R., Alvarez-Moreno C., Burhan E., Chariyalertsak S., Chiu N.C., Chuenkitmongkol S., et al. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expet Rev Vaccine. 2023;22:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">36330971</ArticleId></ArticleIdList></Reference><Reference><Citation>SLIPE  Gu&#xed;a sobre Vacunaci&#xf3;n para COVID en Ni&#xf1;os. https://slipe.org/web/wp-content/uploads/2023/04/Publicacion-vacunas-covid-ninios.pdf. 2023</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>